Azithromycin IP / USP
Azalide macrolide in IP and USP grade — same active compound across both pharmacopoeial standards, differing only in monograph specification. Sourced for respiratory tract and sexually transmitted infection treatment protocols.
Pharmaceutical & Life Science Solutions
Broad-spectrum macrolide antibiotics with unique tissue penetration and intracellular accumulation profiles. Active against atypical organisms, respiratory, and STI-associated pathogens.
Azalide macrolide in IP and USP grade — same active compound across both pharmacopoeial standards, differing only in monograph specification. Sourced for respiratory tract and sexually transmitted infection treatment protocols.
14-membered semisynthetic macrolide in pharmaceutical grade for tablet and suspension formulation manufacturing. Sourced for respiratory tract infections and H. pylori eradication therapy product lines.
Original 14-membered macrolide in USP/EP grade for powder, tablet, and suspension formulation manufacturing. Sourced for respiratory tract infections, skin infections, and acne treatment protocols.
Propionate ester salt of erythromycin in EP/USP grade for oral suspension formulation manufacturing, offering enhanced gastrointestinal absorption. Sourced for paediatric respiratory infection product lines.
Acid-stable stearate salt of erythromycin in BP/USP grade for tablet formulation manufacturing, offering reduced gastric upset versus the base form. Sourced for respiratory tract infection treatment protocols.
Aminoglycoside antibiotic supplied as sulfate salt for injectable formulation manufacturing. Sourced for severe gram-negative bacterial infection protocols. Note: classified pharmacologically as an aminoglycoside, not a macrolide.
Semi-synthetic macrolide with enhanced oral bioavailability in pharmaceutical grade for tablet formulation manufacturing. Sourced for upper and lower respiratory tract infection treatment protocols.